Training the cannabis scientists of tomorrow has never been more important

How are Canadians using medical cannabis?

Freeing the roads of THC-intoxicated drivers, one breathalyzer test at a time

The message is clear: we need more evidence. But are randomized, controlled trials the answer?

Does CBD really counteract the neuropsychiatric risks of THC?

Could synthetic biology facilitate a microbial revolution... and do away with grow rooms for good?

Heavy metal contaminants pose a risk to health – the cannabis industry must react accordingly.

Sitting Down With... Mike Barnes, Chief Medical Officer, Lyphe Group, London, UK and Chairman, Maple Tree Consultancy, Chester, UK.

A dose-escalation study aims to quantify the value of CBD in children with epileptic encephalopathy.

Restrictive legislation won’t prevent efforts to progress cannabis research